Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis

A SIMPLE METHOD FOR THE ISOLATION AND PURIFICATION OF TOTAL LIPIDES FROM ANIMAL TISSUES

Folch, J., Lees, M., & Stanley, G. H. S. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64849-5 · Cited by 65,189

Design and validation of a histological scoring system for nonalcoholic fatty liver disease†

Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791

Prevalence of Obesity Among Adults and Youth: United States, 2015-2016.

Hales, C. M., Carroll, M. D., Fryar, C. D., & Ogden, C. L. (2017) · PubMed · Cited by 3,889

Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis

Sanyal, A. J., Chalasani, N., Kowdley, K. V., McCullough, A., Diehl, A. M., Bass, N. M., Neuschwander-Tetri, B. A., Lavine, J. E., Tonascia, J., Unalp, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907929 · Cited by 3,327

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

Angulo, P., Kleiner, D. E., Dam-Larsen, S., Adams, L. A., Bjornsson, E. S., Charatcharoenwitthaya, P., Mills, P. R., Keach, J. C., Lafferty, H. D., Stahler, A., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.043 · Cited by 2,987

Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver

Friedman, S. L. (2008) · Physiological Reviews · doi:10.1152/physrev.00013.2007 · Cited by 2,842

Nonalcoholic Fatty Liver Disease

Rinella, M. E. (2015) · JAMA · doi:10.1001/jama.2015.5370 · Cited by 2,320

Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up

Ekstedt, M., Hagström, H., Nasr, P., Fredrikson, M., Stål, P., Kechagias, S., & Hultcrantz, R. (2015) · Hepatology · doi:10.1002/hep.27368 · Cited by 2,287

Obesity and Diabetes in the Developing World — A Growing Challenge

Hossain, P., Kawar, B., & El Nahas, M. (2007) · New England Journal of Medicine · doi:10.1056/nejmp068177 · Cited by 2,200

Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta‐analysis

Dulai, P. S., Singh, S., Patel, J., Soni, M., Prokop, L. J., Younossi, Z., Sebastiani, G., Ekstedt, M., Hagstrom, H., Nasr, P., et al. (2017) · Hepatology · doi:10.1002/hep.29085 · Cited by 1,965

OPN‐Mediated Crosstalk Between Hepatocyte E4BP4 and Hepatic Stellate Cells Promotes MASH‐Associated Liver Fibrosis

Wang, S., Gao, J., Yang, M., Zhang, G., Yin, L., & Tong, X. (2024) · Advanced Science · doi:10.1002/advs.202405678 · Cited by 26

Inhibition of Notch1 signaling reduces hepatocyte injury in nonalcoholic fatty liver disease via autophagy

Zhang, M., Wu, P., Li, M., Guo, Y., Tian, T., Liao, X., & Tan, S. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.02.039 · Cited by 23

Differential genetic diagnoses of adult post-lingual hearing loss according to the audiogram pattern and novel candidate gene evaluation

Rim, J. H., Noh, B., Koh, Y. I., Joo, S. Y., Oh, K. S., Kim, K., Kim, J. A., Kim, D. H., Kim, H., Yoo, J. E., et al. (2021) · Human Genetics · doi:10.1007/s00439-021-02367-z · Cited by 23

Effects of Oat β-Glucan and Inulin on Alleviation of Nonalcoholic Steatohepatitis Aggravated by Circadian Disruption in C57BL/6J Mice

Kei, N., Cheung, K. K., Lee, K., Yau, T. K., Lauw, S., Wong, V. W., You, L., & Cheung, P. C. K. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c08028 · Cited by 23

Dissecting the mechanisms of MASLD fibrosis in the era of single-cell and spatial omics

Colella, F., Henderson, N. C., & Ramachandran, P. (2025) · Journal of Clinical Investigation · doi:10.1172/jci186421 · Cited by 25

Liver sphingomyelin synthase 1 deficiency causes steatosis, steatohepatitis, fibrosis, and tumorigenesis: An effect of glucosylceramide accumulation

Li, Z., Chiang, Y.-P., He, M., Worgall, T. S., Zhou, H., & Jiang, X. (2021) · iScience · doi:10.1016/j.isci.2021.103449 · Cited by 19

Decoding liver fibrogenesis with single-cell technologies

Zhou, T., Musunuru, K., Lui, K. O., & Ding, Q. (2022) · Life Medicine · doi:10.1093/lifemedi/lnac040 · Cited by 22

Emerging novel targets for nonalcoholic fatty liver disease treatment: Evidence from recent basic studies

Wang, G., Zhang, X., Wang, C., & Guan, Y. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i1.75 · Cited by 21

Diagnostic accuracy and prognostic significance of osteopontin in liver cirrhosis and hepatocellular carcinoma: a Meta-analysis

Zhang, Y., Gao, J., Bao, Y. J., Liu, Y., Tong, Y., Jin, S., & Zhao, Q. (2021) · Biomarkers · doi:10.1080/1354750x.2021.2008009 · Cited by 20

Spatial immunophenotypes predict clinical outcome in intrahepatic cholangiocarcinoma

Zhu, C., Ma, J., Zhu, K., Yu, L., Zheng, B., Rao, D., Zhang, S., Dong, L., Gao, Q., Zhang, X., et al. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2023.100762 · Cited by 20

Hepatocyte-targeted siTAZ therapy lowers liver fibrosis in NASH diet-fed chimeric mice with hepatocyte-humanized livers

Wang, X., Moore, M. P., Shi, H., Miyata, Y., Donnelly, S. K., Radiloff, D. R., & Tabas, I. (2023) · Molecular Therapy Methods & Clinical Development · doi:10.1016/j.omtm.2023.101165 · Cited by 21

Jagged-mediated development and disease: Mechanistic insights and therapeutic implications for Alagille syndrome

Mašek, J., & Andersson, E. R. (2024) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2023.102302 · Cited by 25

Hepatocyte Notch Signaling Deregulation Related to Lipid Metabolism in Women with Obesity and Nonalcoholic Fatty Liver

Auguet, T., Bertran, L., Binetti, J., Aguilar, C., Martínez, S., Guiu‐Jurado, E., Sabench, F., Adalid, L., Porras, J. A., Riesco, D., et al. (2020) · Obesity · doi:10.1002/oby.22873 · Cited by 20

Liver fibrosis in fish research: From an immunological perspective

Cao, Q., Shan, H., Zhao, J., Deng, J., Xu, M., Kang, H., Li, T., Zhao, Y., Liu, H., & Jiang, J. (2023) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2023.108885 · Cited by 19

New approaches to the treatment of metabolic dysfunction-associated steatotic liver with natural products

Yadav, P., Quadri, K., Kadian, R., Waziri, A., Agrawal, P., & Alam, M. S. (2024) · iLiver · doi:10.1016/j.iliver.2024.100131 · Cited by 19

AAV-delivered muscone-induced transgene system for treating chronic diseases in mice via inhalation

Wu, X., Yu, Y., Wang, M., Dai, D., Yin, J., Liu, W., Kong, D., Tang, S., Meng, M., Gao, T., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45383-z · Cited by 19

Can Nutraceuticals Support the Treatment of MASLD/MASH, and thus Affect the Process of Liver Fibrosis?

Sokal-Dembowska, A., Jarmakiewicz-Czaja, S., Ferenc, K., & Filip, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105238 · Cited by 19

Therapeutic Targets and Approaches to Manage Inflammation of NAFLD

Geng, W., Liao, W., Cao, X., & Yang, Y. (2025) · Biomedicines · doi:10.3390/biomedicines13020393 · Cited by 20

Deubiquitylase OTUD1 confers Erlotinib sensitivity in non-small cell lung cancer through inhibition of nuclear translocation of YAP1

Liu, H., Zhong, L., Lu, Y., Liu, X., Wei, J., Ding, Y., Huang, H., Nie, Q., & Liao, X. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01119-w · Cited by 18

Antisense oligonucleotides targeting Notch2 ameliorate the osteopenic phenotype in a mouse model of Hajdu-Cheney syndrome

CANALIS, E. M., Grossman, T. R., Carrer, M., Schilling, L., & Yu, J. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.011440 · Cited by 18

Intrahepatic osteopontin signaling by CREBZF defines a checkpoint for steatosis-to-NASH progression

Ma, F., Liu, Y., Hu, Z., Xue, Y., Liu, Z., Cai, G., Su, W., Zheng, Z., Xia, F., Yan, X., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000042 · Cited by 19

Integration of deep learning-based histopathology and transcriptomics reveals key genes associated with fibrogenesis in patients with advanced NASH

Conway, J. R., Pouryahya, M., Gindin, Y., Pan, D. Z., Carrasco‐Zevallos, O. M., Mountain, V., Subramanian, G. M., Montalto, M., Resnick, M. B., Beck, A. H., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101016 · Cited by 18

Empagliflozin ameliorates liver fibrosis in NASH rat model via targeting hepatic NF-κB/SOX9/OPN signaling and osteocalcin level

Elseweidy, M. M., Ali, A. A., Hassanin, S. M., & Mahmoud, Y. K. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02826-6 · Cited by 17

Exploring Fibrosis Pathophysiology in Lean and Obese Metabolic-Associated Fatty Liver Disease: An In-Depth Comparison

Vesković, M. N., Pejović, M., Šutulović, N., Hrnčić, D., Rašić-Marković, A., Stanojlović, O. P., & Mladenović, D. R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137405 · Cited by 19

Does Mechanocrine Signaling by Liver Sinusoidal Endothelial Cells Offer New Opportunities for the Development of Anti-fibrotics?

Soydemir, S., Comella, O., Abdelmottaleb, D. I., & Pritchett, J. P. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2019.00312 · Cited by 17

Restorative effect of adipose tissue-derived stem cells on impaired hepatocytes through Notch signaling in non-alcoholic steatohepatitis mice

Ishida, K., Seki, A., Kawaguchi, K., Nasti, A., Yamato, M., Inui, H., Komura, T., Yamashita, T., Arai, K., Yamashita, T., et al. (2021) · Stem Cell Research · doi:10.1016/j.scr.2021.102425 · Cited by 16

Tissue regeneration: Unraveling strategies for resolving pathological fibrosis

Li, J., Wang, S., Yuan, J., Mao, X., Wang, X., Zhang, L., Dong, Q., Chen, Z., Wang, Y., & Tang, N. (2025) · Cell stem cell · doi:10.1016/j.stem.2025.10.002 · Cited by 19

High-resolution in situ structures of hantavirus glycoprotein tetramers

Guo, L., McFadden, E., Slough, M. M., Stone, E. T., Berrigan, J. L., Mittler, E., Hatzakis, K., Hinkley, T. C., Kain, H. S., Ke, Z., et al. (2026) · Cell · doi:10.1016/j.cell.2026.01.030 · Cited by 19

Notch-mediated Ephrin signaling disrupts islet architecture and β cell function

Bartolomé, A., Suda, N., Yu, J., Zhu, C., Son, J., Ding, H., Califano, A., Accili, D., & Pajvani, U. B. (2022) · JCI Insight · doi:10.1172/jci.insight.157694 · Cited by 15

BMP-4 and BMP-7 Inhibit EMT in a Model of Anterior Subcapsular Cataract in Part by Regulating the Notch Signaling Pathway

Jiang, F., Qin, Y., Yang, Y., Li, Z., Cui, B., Ju, R., & Wu, M. (2023) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.64.4.12 · Cited by 15

Adeno-Associated Virus Serotype 8-Mediated Genetic Labeling of Cholangiocytes in the Neonatal Murine Liver

Lee, S., Zhou, P., Whyte, S., & Shin, S. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12040351 · Cited by 15

Inhibition of hyaluronan synthesis by 4-methylumbelliferone ameliorates non-alcoholic steatohepatitis in choline-deficient l-amino acid-defined diet-induced murine model

Yang, Y. M., Wang, Z., Matsuda, M., & Seki, E. (2021) · Archives of Pharmacal Research · doi:10.1007/s12272-021-01309-7 · Cited by 15

TKF, a mexicanolide-type limonoid derivative, suppressed hepatic stellate cells activation and liver fibrosis through inhibition of the YAP/Notch3 pathway

Yang, T., Wu, E., Zhu, X., Leng, Y., Ye, S., Dong, R., Liu, J., Zhong, J., Zheng, Y., Xu, W., et al. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154466 · Cited by 14

Key regulators of hepatic stellate cell activation in alcohol liver Disease: A comprehensive review

Patidar, P., Hirani, N., Bharti, S., & Baig, M. S. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112938 · Cited by 16

Regulatory long non‑coding RNAs of hepatic stellate cells in liver fibrosis (Review)

Wu, Z., Huang, S., Zheng, X., Gu, S., Xu, Q., Gong, Y., Zhang, J., Fu, B., & Tang, L. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.9782 · Cited by 14

Hepatocyte CD36 protects mice from NASH diet-induced liver injury and fibrosis via blocking N1ICD production

Li, Y., Zhang, L., Jiao, J., Ding, Q., Li, Y., Zhao, Z., Luo, J., Chen, Y., Ruan, X. Z., & Zhao, L. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166800 · Cited by 16

CD36 in liver diseases

Liu, Y., & Yin, W. (2025) · Hepatology Communications · doi:10.1097/hc9.0000000000000623 · Cited by 15

The Skeleton of Lateral Meningocele Syndrome

CANALIS, E. M. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2020.620334 · Cited by 13

Lipid-injured hepatocytes release sOPN to improve macrophage migration via CD44 engagement and pFak-NFκB signaling

Jiang, X., Zhang, F., Ji, X., Dong, F., Yu, H., Xue, M., Qiu, Y., Yang, F., Hu, X., & Bao, Z. (2021) · Cytokine · doi:10.1016/j.cyto.2021.155474 · Cited by 13

Inflammatory and Non-Inflammatory Mechanisms Controlling Cirrhosis Development

Sánchez, P. S., Rigual, M. D. M., & Djouder, N. (2021) · Cancers · doi:10.3390/cancers13205045 · Cited by 13

ARMCX3 Mediates Susceptibility to Hepatic Tumorigenesis Promoted by Dietary Lipotoxicity

Mirra, S., Gavaldà-Navarro, A., Manso, Y., Higuera, M., Serrat, R., Salcedo, M., Burgaya, F., Balibrea, J., Santamaría, E., Uriarte, I., et al. (2021) · Cancers · doi:10.3390/cancers13051110 · Cited by 11

Jiawei Taohe Chengqi decoction inhibition of the notch signal pathway affects macrophage reprogramming to inhibit HSCs activation for the treatment of hepatic fibrosis

Shao, C., Xu, H., Sun, X., Pan, Y., Liang, X., Huang, J., He, Y., Guo, W., Ye, L., & Zhang, J. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117486 · Cited by 12

Diverse functions of SOX9 in liver development and homeostasis and hepatobiliary diseases

Shang, T., Jiang, T., Cui, X., Pan, Y., Feng, X., Dong, L., & Wang, H. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.03.035 · Cited by 14

Targeting of Secretory Proteins as a Therapeutic Strategy for Treatment of Nonalcoholic Steatohepatitis (NASH)

Kim, K., & Kim, K. H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072296 · Cited by 13

Ductular reaction in non-alcoholic fatty liver disease: When Macbeth is perverted

He, Y.-H., Pan, J., Xu, L., Gu, T., & Chen, Y. (2023) · World Journal of Hepatology · doi:10.4254/wjh.v15.i6.725 · Cited by 11

Endoplasmic reticulum stress in liver fibrosis: Mechanisms and therapeutic potential

Wang, T., Xia, G., Li, X., Gong, M., & Lv, X. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167695 · Cited by 13

Engineering Modular 3D Liver Culture Microenvironments In Vitro to Parse the Interplay between Biophysical and Biochemical Microenvironment Cues on Hepatic Phenotypes

Wang, A. J.-S., Allen, A., Sofman, M., Sphabmixay, P., Yıldız, E., & Griffith, L. G. (2021) · Advanced NanoBiomed Research · doi:10.1002/anbr.202100049 · Cited by 11

Liver-selective γ-secretase inhibition ameliorates diet-induced hepatic steatosis, dyslipidemia and atherosclerosis

Kim, K., Yu, J., Kang, J. K., Morrow, J. P., & Pajvani, U. B. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.04.157 · Cited by 11

Expression of Notch family is altered in non‑alcoholic fatty liver disease

Ding, W., Wu, W., Chen, Y., Chen, H., Fan, J., & Qiao, L. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11249 · Cited by 11

Consequences of Amyloid‐β Deficiency for the Liver

Buniatian, G. H., Schwinghammer, U., Tremmel, R., Cynis, H., Weiß, T. S., Weiskirchen, R., Lauschke, V. M., Youhanna, S. C., Ramos, I., Valcárcel, M., et al. (2024) · Advanced Science · doi:10.1002/advs.202307734 · Cited by 9

Androgen Effects on Alcohol-induced Liver Fibrosis Are Controlled by a Notch-dependent Epigenetic Switch

Nataraj, K., Schonfeld, M. P., Rodriguez, A., Sharma, M., Weinman, S. A., & Tikhanovich, I. (2024) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2024.101414 · Cited by 10

Natural small molecule hinokitone mitigates NASH fibrosis by targeting regulation of FXR-mediated hepatocyte apoptosis

Ma, Z.-J., Qiu, Y., Yu, Z.-W., Song, T., Hu, Y., Peng, A., & Qi, R. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.12.016 · Cited by 10

Periostin-mediated NOTCH1 activation between tumor cells and HSCs crosstalk promotes liver metastasis of small cell lung cancer

Lou, L., Peng, K., Ouyang, S., Ding, W., Mo, J., Yan, J., Gong, X., Liu, G., Lu, J., Yue, P., et al. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03266-7 · Cited by 10

The role of the Notch pathway in the pathogenesis of systemic sclerosis: clinical implications

Paula, F. S., & Alves, J. D. (2021) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2021.2000391 · Cited by 10

Redefining senescence through hepatocyte fate changes in liver diseases

Umbaugh, D. S., Diehl, A. M., & Du, K. (2025) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2025.08.003 · Cited by 10

The Emerging Challenge of Non-Cirrhotic MASLD-Related Hepatocellular Carcinoma: Etiology, Immunopathology, and Precision Oncology

Liu, Y. (2025) · Liver Cancer · doi:10.1159/000550163 · Cited by 12

A Quantitative Systems Pharmacology Platform Reveals NAFLD Pathophysiological States and Targeting Strategies

Lefever, D. E., Miedel, M. T., Pei, F., DiStefano, J. K., DeBiasio, R., Shun, T. Y., Saydmohammed, M., Chikina, M. D., Vernetti, L. A., Soto–Gutiérrez, A., et al. (2022) · Metabolites · doi:10.3390/metabo12060528 · Cited by 12

Interactive Role of Surrogate Liver Fibrosis Assessment and Insulin Resistance on the Incidence of Major Cardiovascular Events

Martínez‐Urbistondo, D., D’Avola, D., Navarro‐González, D., Sánchez‐Íñigo, L., Fernández‐Montero, A., Pérez-Díaz-del-Campo, N., Bugianesi, E., Martínez, J. A., & Delgado, J. P. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11175190 · Cited by 10

Interdisciplinary advances reshape the delivery tools for effective NASH treatment

Chen, L., & Wang, Y. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101730 · Cited by 9

Integrated analysis of potential gene crosstalk between non-alcoholic fatty liver disease and diabetic nephropathy

Yan, Q., Zhao, Z., Liu, D., Li, J., Pan, S., Duan, J., Dong, J., & Liu, Z. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1032814 · Cited by 8

Integrative radiomics analyses identify universal signature for predicting prognosis and therapeutic vulnerabilities across primary and secondary liver cancers: a multi-cohort study.

Xin, H.-J., Lai, Q., Liu, Y.-P., Liao, N., Wang, Y., Liao, B.-H., Zhou, K., Zhou, Y.-C., Bai, Y., Chen, Z., et al. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107535 · Cited by 8

Celastrol ameliorates fibrosis in Western diet/tetrachloromethane-induced nonalcoholic steatohepatitis by suppressing Notch/osteopontin signaling

Li, D., Chen, J., Ye, C., Lin, B., Zhang, T., Chen, Q., Yu, C., & Wan, X. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.156369 · Cited by 8

Genomic medicine in hepatology: mechanisms and liver treatment strategies

Kozlov, D., Rodimova, S. A., Filatov, P. V., Mozherov, A. M., Timashev, P. S., Zyuzin, M. V., & Kuznetsova, D. S. (2025) · Molecular Medicine · doi:10.1186/s10020-025-01358-4 · Cited by 9

Bariatric Surgery Associates with Nonalcoholic Steatohepatitis/Hepatocellular Carcinoma Amelioration via SPP1 Suppression

Chen, S., Tang, L., Guillot, A., & Liu, H. (2022) · Metabolites · doi:10.3390/metabo13010011 · Cited by 8

Protective hepatocyte signals restrain liver fibrosis in metabolic dysfunction–associated steatohepatitis

Steffani, M., Geng, Y., Pajvani, U. B., & Schwabe, R. F. (2024) · Journal of Clinical Investigation · doi:10.1172/jci179710 · Cited by 9

Gossypetin targets the liver-brain axis to alleviate pre-existing liver fibrosis and hippocampal neuroinflammation in mice

Xu, C., Tai, H., Chu, Y., Liu, Y., He, J., Wang, Y., Su, B., & Li, S. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1385330 · Cited by 8

Hepatic stearoyl-CoA desaturase-1 deficiency induces fibrosis and hepatocellular carcinoma-related gene activation under a high carbohydrate low fat diet

Ntambi, J.-N., Kalyesubula, M., Cootway, D., Lewis, S. A., Phang, Y. X., Liu, Z., O’Neill, L. M., Lefers, L., Huff, H., Miller, J. R., et al. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2024.159538 · Cited by 9

Targeting NOTCH1-KEAP1 axis retards chronic liver injury and liver cancer progression via regulating stabilization of NRF2

Chang, C., Wang, M., Li, J., Qi, S., Yu, X., Xu, J., & Shi, S. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03488-3 · Cited by 9

Reactive Oxygen Species-Responsive Delivery of a Notch Inhibitor to Alleviate Nonalcoholic Steatohepatitis by Inhibiting Hepatic de Novo Lipogenesis and Inflammation

Chen, J.-H., Zhang, J., Xia, Y., Li, J., Jia, Q., Zhang, Z., Jing, X., Xu, Y., Zou, L., Wang, L., et al. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.4c00070 · Cited by 7

Macrophages Serve as Bidirectional Regulators and Potential Therapeutic Targets for Liver Fibrosis

Liang, W. H., Huang, X., & Shi, J. (2023) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-023-01173-w · Cited by 8

Jagged-1/Notch Pathway and Key Transient Markers Involved in Biliary Fibrosis during Opisthorchis felineus Infection

Kovner, A. V., Zaparina, O. G., Kapushchak, Y. K., Minkova, G., Mordvinov, V. A., & Pakharukova, M. Y. (2022) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed7110364 · Cited by 7

Jag1 insufficiency alters liver fibrosis via T cell and hepatocyte differentiation defects

Mašek, J., Filipovic, I., Hul, N. V., Belicová, L., Jiroušková, M., Oliveira, D. V., Frontino, A. M., Hankeová, S., He, J., Turetti, F., et al. (2024) · EMBO Molecular Medicine · doi:10.1038/s44321-024-00145-8 · Cited by 6

Biliary YB-1/GLI2 axis facilitates ductular reaction and promotes HSC activation via SPP1/integrin αvβ1 signaling during liver fibrogenesis

Guo, Y., Zhang, Q., Li, B., Dai, W., Shen, B., Shen, Z., Wang, J., Ge, Q., Zhangdi, H., Chen, G., et al. (2025) · Hepatology · doi:10.1097/hep.0000000000001458 · Cited by 7

Complex I Modulator BI4500 Reduces MASH by Limiting Oxidative Stress and Reprogramming Lipid Metabolism via AMPK in MCD Rats

Pasqua, L. G. D., Lotti, S., Trucchi, M., Palladini, G., Croce, A. C., Protopapa, F., Feletti, F., Kauschke, S. G., Sun, P., Vairetti, M., et al. (2026) · Antioxidants · doi:10.3390/antiox15010082 · Cited by 6

NHE1 regulation in NAFLD in vitro contributes to hepatocyte injury and HSC crosstalk

Sjøgaard-Frich, L. M., Henriksen, M. S., Lam, S., Birkbak, F. J., Czaplińska, D., Flinck, M., & Pedersen, S. F. (2024) · Journal of Endocrinology · doi:10.1530/joe-24-0099 · Cited by 6

Influence of Sex in the Development of Liver Diseases

Zhang, J., Zhang, N., Lyu, Y., & Zhang, X. (2025) · Seminars in Liver Disease · doi:10.1055/a-2516-0261 · Cited by 7

Recent Updates on the Therapeutic Prospects of Reversion-Inducing Cysteine-Rich Protein with Kazal Motifs (RECK) in Liver Injuries

Palladini, G., Pasqua, L. G. D., Croce, A. C., Ferrigno, A., & Vairetti, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417407 · Cited by 6

Liver fibrosis pathologies and potentials of RNA based therapeutics modalities

Diwan, R., Gaytan, S. L., Bhatt, H. N., Pena‐Zacarias, J., & Nurunnabi, M. (2024) · Drug Delivery and Translational Research · doi:10.1007/s13346-024-01551-8 · Cited by 6

The Role of RECK in Hepatobiliary Neoplasia Reveals Its Therapeutic Potential in NASH

Dashek, R. J., Diaz, C., Chandrasekar, B., & Rector, R. S. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.770740 · Cited by 6

Molecular mechanism by which the Notch signaling pathway regulates autophagy in a rat model of pulmonary fibrosis in pigeon breeder’s lung

Li, Y., Lian, Z., Li, Q., Ding, W., Wang, W., Zhang, L., Muhataer, X., Zhou, Y., Yang, X. R., & Wu, C. (2023) · Open Medicine · doi:10.1515/med-2023-0629 · Cited by 6

Rap1 Activation Protects Against Fatty Liver and Non-Alcoholic Steatohepatitis DevelopmentPreprint

Agarwal, H., Wang, Y., & Özcan, L. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.24.563728 · Cited by 10

Pathogenesis and management of metabolic dysfunction-associated steatohepatitis-related hepatocellular carcinoma: a narrative review

Lee, H. A. (2024) · Ewha Medical Journal · doi:10.12771/emj.2024.e65 · Cited by 5

SOX9: a key transcriptional regulator in organ fibrosis

Li, Y., Xing, Y., Liu, N., Liu, B., & Wang, Z.-H. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1507282 · Cited by 9

Paired snRNA-seq and scRNA-seq analysis of MASLD patients to identify early-stage markers for disease progression

Park, S., Lee, S.-H., Han, S.-E., Kim, B. K., & Hwang, B. (2025) · Hepatology Communications · doi:10.1097/hc9.0000000000000820 · Cited by 7

A new liver-targeted agonist of thyroid hormone receptor beta resmetirom in treating MASLD/MASH: From mechanism to therapy

Liu, M., Ma, Y., Cheang, W. S., Su, Z., & Xu, S. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.04.011 · Cited by 8

RAP1A suppresses hepatic steatosis by regulating amino acid-mediated mTORC1 activation

Agarwal, H., Wang, Y., Tinsley, B., Wang, X., & Özcan, L. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2024.101303 · Cited by 5

β-cell Jagged1 is sufficient but not necessary for islet Notch activity and insulin secretory defects in obese mice

Suda, N., Bartolomé, A., Liang, J., Son, J., Yagishita, Y., Siebel, C. W., Accili, D., Ding, H., & Pajvani, U. B. (2024) · Molecular Metabolism · doi:10.1016/j.molmet.2024.101894 · Cited by 5

The effect and application of adiponectin in hepatic fibrosis

Chen, T., Yang, W., Dong, R., Yao, H., Sun, M., Wang, J., Zhou, Q. G., & Xu, J. (2023) · Gastroenterology report · doi:10.1093/gastro/goae108 · Cited by 5

Use of antisense oligonucleotides to target Notch3 in skeletal cells

CANALIS, E. M., Carrer, M., Eller, T., Schilling, L., & Yu, J. (2022) · PLoS ONE · doi:10.1371/journal.pone.0268225 · Cited by 5

Expression of nicastrin, NICD1, and Hes1 in NCSTN knockout mice: implications for hidradenitis suppurativa, Alzheimer’s, and liver cancer

Lu, Y., Song, Y., Zhou, J., Zhu, L., Shi, T.-W., Yu, H.-Q., Dong, Z.-Q., Wang, W. J., Long, T., Liu, H.-Y., et al. (2024) · European journal of medical research · doi:10.1186/s40001-024-02225-4 · Cited by 4

The Emerging Role of Anti-Hyperglycemic Agents for the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease

Pieralice, S., Amendolara, R., Berna, V., Manganaro, G., Zurru, A., D’Onofrio, L., Risi, R., Alfonsi, M., Maddaloni, E., & Buzzetti, R. (2025) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s528569 · Cited by 7

Hepatocyte KCTD17-mediated SERPINA3 inhibition determines liver fibrosis in metabolic dysfunction-associated steatohepatitis

Jeong, Y., Oh, A., Jung, Y. H., Jung, K. H., Lee, S., Carrer, M., Lee, S. B., Valenti, L. V. C., Pajvani, U. B., & Kim, K. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01499-w · Cited by 4

Extracellular matrix stiffness in hepatocellular carcinoma: mechanisms and targeted therapeutic strategies

Zhou, Z., & Xu, X. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1773909 · Cited by 5

Mitochondrial Dysfunction in Metabolic-Syndrome-Related MASLD/MASH: Metabolic Mechanisms and Therapeutic Perspectives

Jin, J., & Yang, C. C.-K. (2026) · Metabolites · doi:10.3390/metabo16070489 · Cited by 5

Kisspeptin Alleviates Human Hepatic Fibrogenesis by Inhibiting TGFβ Signaling in Hepatic Stellate Cells

Prasad, K., Bhattacharya, D., Shams, S. G. E., Izarraras, K., Hart, T., Mayfield, B., Blaszczyk, M. B., Zhou, Z., Pajvani, U. B., Friedman, S. L., et al. (2024) · Cells · doi:10.3390/cells13191651 · Cited by 7

Dual inhibition of EGR1/STAT3 transcriptional hubs suppresses macrophage-driven liver fibrosis: A multi-omics-guided drug repurposing strategy

Mijit, A., Zhang, Y., Wu, Y., Li, M., Wang, Z., & Cheng, L.-F. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117120 · Cited by 5

Profiling of mouse and human liver diseases identifies targets for therapeutic treatment of autoimmune hepatitis

Centa, M., Thermidor, C., Fiel, M. I., & Alexandropoulos, K. (2023) · Clinical Immunology · doi:10.1016/j.clim.2023.109807 · Cited by 4

A Golden Shield: The Protective Role of Curcumin against Liver Fibrosis

Abolfazli, S., Butler, A. E., Jamialahmadi, T., & Sahebkar, A. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867331666230821095329 · Cited by 5

Super-enhancer signature reveals key mechanisms associated with resistance to non-alcoholic steatohepatitis in humans with obesityPreprint

Hung, Y.-H., Sritharan, R., Vohl, M., Ilkayeva, O., Biertho, L. D., Tchernof, A., White, P. J., & Sethupathy, P. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.20.457162 · Cited by 4

Thyroid-Stimulating Hormone: An Important Target for the Prevention of Nonalcoholic Fatty Liver Disease

Wang, Z., Wang, H., & Sun, H. (2025) · Physiological Research · doi:10.33549/physiolres.935453 · Cited by 3

Hepatocyte Notch in non-alcoholic steatohepatitis (NASH)-associated liver fibrosis and cancer

Zhu, C. (2019) · doi:10.7916/d8-877b-v389

Notch-mediated hepatocyte MCP-1 secretion causes liver fibrosis

Kang, J., Postigo, J., Kim, K., Zhu, C., Yu, J., Meroni, M., Mayfield, B., Bartolomé, A., Dapito, D. H., Ferrante, A. W., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.165369 · Cited by 80

Notch and Nonalcoholic Fatty Liver and Fibrosis

Romeo, S. (2019) · New England Journal of Medicine · doi:10.1056/nejmcibr1815636 · Cited by 49

Hepatocyte TLR4 triggers inter-hepatocyte Jagged1/Notch signaling to determine NASH-induced fibrosis

Yu, J., Zhu, C., Wang, X., Kim, K., Bartolome, A., Dongiovanni, P., Yates, K. P., Valenti, L., Carrer, M., Sadowski, T., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abe1692 · Cited by 132

Notch‐triggered maladaptation of liver sinusoidal endothelium aggravates nonalcoholic steatohepatitis through endothelial nitric oxide synthase

Fang, Z., Ruan, B., Liu, J., Duan, J., Yue, Z., Song, P., Xu, H., Ding, J., Xu, C., Dou, G., et al. (2022) · Hepatology · doi:10.1002/hep.32332 · Cited by 91